MedPath

BYLVAY

BYLVAY

Approved
DIN Number

02542676

Drug Class

Human

Market Date

Feb 7, 2024

Company
HC

medison pharma canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02542676
AIG Number0165181002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A05AX05 ODEVIXIBAT
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ODEVIXIBATActive
Strength: 400 MCG
Monograph: ODEVIXIBAT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.